Information  X 
Enter a valid email address

Arix Bioscience PLC 0.001P (ARIX)

Date Time Source Announcement
10 Aug 2020 12:49 pm
PRN
LogicBio announces IND clearance for LB-001
31 Jul 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:01 am
PRN
Total Voting Rights
20 Jul 2020 1:28 pm
PRN
Amplyx announces positive Phase 2 data
10 Jul 2020 7:53 am
PRN
Atox Bio plans NDA submission for Q3 2020
08 Jul 2020 1:27 pm
PRN
VelosBio completes $137 million Series B financing
01 Jul 2020 7:00 am
PRN
Director/PDMR Shareholding, Issue of Ordinary Shares
12 Jun 2020 2:24 pm
PRN
Aura presents updated AU-011 clinical data at ARVO 2020
  1:34 pm
PRN
Imara presents positive interim Phase 2a data at EHA
  9:13 am
PRN
Autolus AUTO1 and AUTO3 data at EHA
08 Jun 2020 7:08 am
PRN
Arix announces strategic and operational update
04 Jun 2020 5:42 pm
PRN
Results of Annual General Meeting
01 Jun 2020 2:57 pm
PRN
Iterum announces topline Phase 3 data in complicated UTI
29 May 2020 1:38 pm
PRN
Harpoon presents interim Phase 1 data for HPN424
  1:06 pm
PRN
Autolus presents additional AUTO3 data in DLBCL
27 May 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
20 May 2020 7:00 am
PRN
Amplyx closes $53 million Series C extension
19 May 2020 9:35 am
EQS
Arix Bioscience (ARIX): 1Q'20 portfolio update
12 May 2020 7:00 am
PRN
Notice of Annual General Meeting
28 Apr 2020 9:23 am
PRN
Pharmaxis announces new data in myelofibrosis
27 Apr 2020 1:12 pm
PRN
Harpoon doses first patient in multiple myeloma trial
23 Apr 2020 7:30 am
EQS
Arix Bioscience (ARIX): Resetting the stage
17 Apr 2020 2:59 pm
PRN
Director/PDMR Shareholding
16 Apr 2020 1:08 pm
PRN
Autolus announces FDA acceptance of IND application
06 Apr 2020 7:00 am
PRN
Changes to Board of Directors and executive leadership
19 Mar 2020 10:30 am
EQS
Arix Bioscience (ARIX): Fiscal 2019 - moving with the times
16 Mar 2020 7:00 am
PRN
Director/PDMR Shareholding
12 Mar 2020 7:11 am
PRN
Imara prices Nasdaq IPO
10 Mar 2020 7:00 am
PRN
Annual Results for the year ended 31 December 2019
09 Mar 2020 12:00 pm
PRN
Dr Roberto Iacone appointed as EiR
03 Mar 2020 12:18 pm
PRN
Update on Imara proposed IPO in the United States
  7:30 am
EQS
Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)
27 Feb 2020 12:00 pm
PRN
Notice of Results
24 Feb 2020 1:26 pm
PRN
Aura announces updated Phase 1b/2 clinical data
19 Feb 2020 7:30 am
EQS
Arix Bioscience (ARIX) - Initiation of coverage: With high risk can come high reward
17 Feb 2020 7:00 am
PRN
Imara files for proposed IPO in the United States
30 Jan 2020 12:08 pm
PRN
Autolus presents encouraging additional AUTO3 data
27 Jan 2020 7:00 am
PRN
Arix co-founds Quench Bio with Series A financing
23 Jan 2020 7:00 am
PRN
Autolus announces pricing of public offering
17 Jan 2020 1:15 pm
PRN
Iterum announces $52 million private placement
18 Dec 2019 10:00 am
PRN
Pharmaxis business update
17 Dec 2019 10:57 am
PRN
Board changes
11 Dec 2019 7:05 am
PRN
Iterum announces topline Phase 3 data
09 Dec 2019 7:01 am
PRN
Autolus announces new AUTO3 data at ASH
  7:00 am
PRN
Autolus announces key new data at ASH
22 Nov 2019 9:57 am
PRN
Holding(s) in Company
21 Nov 2019 12:06 pm
PRN
Harpoon and AbbVie announce licensing and option deal
07 Nov 2019 12:22 pm
PRN
Autolus reports Q3 2019 financial results
  7:22 am
PRN
Change of Broker
06 Nov 2019 2:31 pm
PRN
Autolus to present new data at the ASH Annual Meeting
  7:02 am
PRN
Artios expands DDR pipeline with new asset
17 Oct 2019 1:40 pm
PRN
Holding(s) in Company
16 Oct 2019 8:00 am
PRN
Aura reports updated Phase 1b/2 clinical data for AU-011
15 Oct 2019 3:20 pm
PRN
]Holding(s) in Company
03 Oct 2019 7:06 am
PRN
2019 Capital Markets Day
02 Oct 2019 7:00 am
PRN
Management change
30 Sep 2019 7:00 am
PRN
Arix co-leads EUR 20m Series A financing in STipe
17 Sep 2019 7:47 am
PRN
Amplyx unveils expanded pipeline and Phase 2 data
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t